These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 4281293)

  • 21. Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics.
    Lapin IP; Oxenkrug GF; Azbekyan SG
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):350-61. PubMed ID: 4260601
    [No Abstract]   [Full Text] [Related]  

  • 22. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF; Buckley JP
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract]   [Full Text] [Related]  

  • 24. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 25. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification of the cerebral serotonin level in the rat by trifluoromethyl-2-phenyl ethyl aminopropane (Fenfluramine 768 S)].
    Duhault J; Verdavainne C
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):276-86. PubMed ID: 5299781
    [No Abstract]   [Full Text] [Related]  

  • 27. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 28. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoamine mediation of the morphine-induced activation of mice.
    Carroll BJ; Sharp PT
    Br J Pharmacol; 1972 Sep; 46(1):124-39. PubMed ID: 4263794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
    Weiss BF; Liebschutz JL; Wurtman RJ; Munro HN
    J Neurochem; 1975 Jun; 24(6):1191-5. PubMed ID: 1079238
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.
    Teychenne PF; Calne DB; Lewis PJ; Findley LJ
    Clin Pharmacol Ther; 1975 Sep; 18(3):273-7. PubMed ID: 1164817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and uptake of 5-hydroxytryptamine by the myenteric plexus of the guinea-pig ileum. A histochemical study.
    Robinson RG; Gershon MD
    J Pharmacol Exp Ther; 1971 Aug; 178(2):311-24. PubMed ID: 4398295
    [No Abstract]   [Full Text] [Related]  

  • 35. Central nervous system mechanisms responsible for blood pressure elevation induced by p-chlorophenylalanine.
    Ito A; Schanberg SM
    J Pharmacol Exp Ther; 1972 Apr; 181(1):65-74. PubMed ID: 4259017
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of catecholaminergic substances on the circular reaction caused by stimulation of the caudate nucleus].
    Dutov AA
    Farmakol Toksikol; 1976; 39(5):537-40. PubMed ID: 1028579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB; Friedman E; Gershon S
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of agents, changing the monoamine level, on audiogenic epileptic seizures in rats].
    Prakh'e IB
    Biull Eksp Biol Med; 1973 Sep; 76(9):23-6. PubMed ID: 4544283
    [No Abstract]   [Full Text] [Related]  

  • 39. [Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation].
    Sato M; Nakashima T; Mitsunobu K; Otsuki S
    No To Shinkei; 1976 May; 28(5):471-7. PubMed ID: 140696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.